These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 9087289)
1. [Ifosfamide chemotherapy ineffective for advanced pancreatic carcinoma]. Fujiki T; Futatsuki K; Akazawa S; Yamamoto K; Kanda Y; Yamato A; Terashi K; Suda Y Gan To Kagaku Ryoho; 1997 Mar; 24(5):569-72. PubMed ID: 9087289 [TBL] [Abstract][Full Text] [Related]
2. [Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study]. Noda K; Hirabayashi K; Terashima Y; Ozaki M; Yakushiji M; Hatae M; Kanazawa K Gan To Kagaku Ryoho; 1997 Aug; 24(10):1285-93. PubMed ID: 9279348 [TBL] [Abstract][Full Text] [Related]
3. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study. Sutton G; Brunetto VL; Kilgore L; Soper JT; McGehee R; Olt G; Lentz SS; Sorosky J; Hsiu JG Gynecol Oncol; 2000 Nov; 79(2):147-53. PubMed ID: 11063636 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma. Kushner DM; Webster KD; Belinson JL; Rybicki LA; Kennedy AW; Markman M Gynecol Oncol; 2000 Aug; 78(2):221-7. PubMed ID: 10926807 [TBL] [Abstract][Full Text] [Related]
5. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS). Maurel J; Fra J; López-Pousa A; García del Muro X; Balañá C; Casado A; Martín J; Martínez-Trufero J; de las Peñas R; Buesa JM; Cancer; 2004 Apr; 100(7):1498-506. PubMed ID: 15042685 [TBL] [Abstract][Full Text] [Related]
7. Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial. Lorusso V; Gebbia V; Spada M; Guida M; Cassano G; Brunetti C; Germano D; Nettis G; Izzi G; Galetta D; Giampaglia M; Silvestris N; Colucci G Oncol Rep; 2005 Dec; 14(6):1547-51. PubMed ID: 16273254 [TBL] [Abstract][Full Text] [Related]
8. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas. Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154 [TBL] [Abstract][Full Text] [Related]
9. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833 [TBL] [Abstract][Full Text] [Related]
10. High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma. Talbot SM; Rankin C; Taub RN; Balcerzak SP; Bhoopalam N; Chapman RA; Baker LH; Middleman EL; Antman KH Cancer; 2003 Jul; 98(2):331-6. PubMed ID: 12872353 [TBL] [Abstract][Full Text] [Related]
11. High-dose ifosfamide in advanced osteosarcoma. Marti C; Kroner T; Remagen W; Berchtold W; Cserhati M; Varini M Cancer Treat Rep; 1985 Jan; 69(1):115-7. PubMed ID: 3855382 [TBL] [Abstract][Full Text] [Related]
12. [Cis-diamminedichloroplatinum(II) chemotherapy in advanced pancreatic carcinoma]. Tajiri H; Yoshimori M; Hijikata A; Nakamura K; Ohkura H; Okazaki N Gan To Kagaku Ryoho; 1987 Nov; 14(11):3101-4. PubMed ID: 3674895 [TBL] [Abstract][Full Text] [Related]
13. [Continuous-infusion high dose ifosfamide as salvage treatment for pre-treated soft tissue sarcoma]. Chen LK; Xu GC; Teng XY; Liang Y; Liu JL; Zhou XM Ai Zheng; 2002 Aug; 21(8):903-6. PubMed ID: 12478904 [TBL] [Abstract][Full Text] [Related]
14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
15. Microencapsulated, CYP2B1-transfected cells activating ifosfamide at the site of the tumor: the magic bullets of the 21st century. Löhr M; Hummel F; Faulmann G; Ringel J; Saller R; Hain J; Günzburg WH; Salmons B Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S21-4. PubMed ID: 12042985 [TBL] [Abstract][Full Text] [Related]
16. [Efficacy of gemcitabine combined oxaliplatin on advanced pancreatic cancer]. Shi YX; Xu RH; Jiang WQ; Zhang L; Lin TY; Li YH; Xia ZJ; Luo HY; Han B; Wang F; He YJ; Guan ZZ Ai Zheng; 2007 Dec; 26(12):1381-4. PubMed ID: 18076807 [TBL] [Abstract][Full Text] [Related]
17. [The first report from Sapporo Tsukisamu Hospital--chemotherapy and chemoradiotherapy for patients with advanced pancreatic cancer]. Yamamitsu S; Kimura H; Yamada Y; Inui N; Hiyama S; Hirata K; Kimura Y; Koito K; Shirasaka T Gan To Kagaku Ryoho; 2007 Jul; 34(7):1059-66. PubMed ID: 17637542 [TBL] [Abstract][Full Text] [Related]
18. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer. Unsal M; Erturk D Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592 [TBL] [Abstract][Full Text] [Related]
19. Prospective randomized clinical trial of two drug delivery pathway in the treatment of inoperable advanced pancreatic carcinoma. Han GH; Yin ZX; Meng XJ; He CY; Zhang HB; Sun AH; Wu KC; Ding J; Fan DM Chin J Dig Dis; 2006; 7(1):45-8. PubMed ID: 16412037 [TBL] [Abstract][Full Text] [Related]